| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Modified Citrus Pectin | Abdominal Aortic Aneurysm | 1 | PM | 28982723 | 📋 | Increased galectin-3 levels are associated with abdominal aortic aneurysm progression and inhibition of galectin-3 decreases elastase-induced AAA development |
| Modified Citrus Pectin | Aortic Valve Stenosis | 1 | PM | 27815266 | 📋 | Role for Galectin-3 in Calcific Aortic Valve Stenosis |
| Modified Citrus Pectin | Arterial Stiffness | 2 | PM | 26351031 | 📋 | Galectin-3 Participates in Cardiovascular Remodeling Associated With Obesity |
| Modified Citrus Pectin | Arterial Stiffness | 1 | PM | 23117656 | 📋 | Galectin-3 mediates aldosterone-induced vascular fibrosis |
| Modified Citrus Pectin | Atherosclerosis | 2 | PM | 28560429 | 📋 | Modified citrus pectin inhibits galectin-3 function to reduce atherosclerotic lesions in apoE-deficient mice |
| Modified Citrus Pectin | Atherosclerosis | 1 | PM | 23426722 | 📋 | Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice |
| Modified Citrus Pectin | Blood-Brain Barrier Permeability | 1 | PM | 30355205 | 📋 | Modified Citrus Pectin Prevents Blood-Brain Barrier Disruption in Mouse Subarachnoid Hemorrhage by Inhibiting Galectin-3 |
| Modified Citrus Pectin | Calcification | 1 | PM | 28758988 | 📋 | Beneficial Effects of Galectin-3 Blockade in Vascular and Aortic Valve Alterations in an Experimental Pressure Overload Model |
| Modified Citrus Pectin | Cardiac Hypertrophy | 1 | PM | 34649308 | 📋 | Modified citrus pectin prevents isoproterenol-induced cardiac hypertrophy associated with p38 signalling and TLR4/JAK/STAT3 pathway |
| Modified Citrus Pectin | Cardiotoxicity | 1 | PM | 38522819 | 📋 | Effect of modified citrus pectin on galectin-3 inhibition in cisplatin-induced cardiac and renal toxicity |
| Modified Citrus Pectin | Cardiovascular Disease | 1 | PM | 29344292 | 📋 | Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update |
| Modified Citrus Pectin | Cerebral Ischemia-Reperfusion | 1 | PM | 35706530 | 📋 | Modified Citrus Pectin Alleviates Cerebral Ischemia/Reperfusion Injury by Inhibiting NLRP3 Inflammasome Activation via TLR4/NF-ĸB Signaling Pathway in Microglia |
| Modified Citrus Pectin | Diabetic Cardiomyopathy | 1 | PM | 32311288 | 📋 | Galectin-3 mediates high-glucose-induced cardiomyocyte injury by the NADPH oxidase/reactive oxygen species pathway |
| Modified Citrus Pectin | Heart Failure | 2 | PM | 29344292 | 📋 | Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update |
| Modified Citrus Pectin | Heart Failure | 1 | PM | 26781273 | 📋 | Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice |
| Modified Citrus Pectin | Hypertension | 2 | PM | 28858976 | 📋 | Galectin-3 pharmacological inhibition attenuates early renal damage in spontaneously hypertensive rats |
| Modified Citrus Pectin | Hypertension | 1 | PM | 28758988 | 📋 | Beneficial Effects of Galectin-3 Blockade in Vascular and Aortic Valve Alterations in an Experimental Pressure Overload Model |
| Modified Citrus Pectin | Ischemic Stroke | 1 | PM | 35706530 | 📋 | Modified Citrus Pectin Alleviates Cerebral Ischemia/Reperfusion Injury by Inhibiting NLRP3 Inflammasome Activation via TLR4/NF-ĸB Signaling Pathway in Microglia |
| Modified Citrus Pectin | Left Ventricular Hypertrophy | 1 | PM | 26781273 | 📋 | Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice |
| Modified Citrus Pectin | Myocardial Fibrosis | 1 | PM | 32172066 | 📋 | Modified citrus pectin ameliorates myocardial fibrosis and inflammation via suppressing galectin-3 and TLR4/MyD88/NF-κB signaling pathway |
| Modified Citrus Pectin | Myocardial Fibrosis | 2 | PM | 31709320 | 📋 | Acute Kidney Injury Induces Remote Cardiac Damage and Dysfunction Through the Galectin-3 Pathway |
| Modified Citrus Pectin | Myocardial Fibrosis | 6 | PM | 26781273 | 📋 | Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice |
| Modified Citrus Pectin | Myocardial Fibrosis | 5 | PM | 26351031 | 📋 | Galectin-3 Participates in Cardiovascular Remodeling Associated With Obesity |
| Modified Citrus Pectin | Myocardial Fibrosis | 4 | PM | 26238446 | 📋 | Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension |
| Modified Citrus Pectin | Myocardial Fibrosis | 3 | PM | 25458174 | 📋 | The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries |
| Modified Citrus Pectin | Myocardial Infarction | 1 | PM | 32172066 | 📋 | Modified citrus pectin ameliorates myocardial fibrosis and inflammation via suppressing galectin-3 and TLR4/MyD88/NF-κB signaling pathway |
| Modified Citrus Pectin | Myocardial Infarction | 2 | PM | 30967790 | 📋 | Perindopril and a Galectin-3 Inhibitor Improve Ischemic Heart Failure in Rabbits by Reducing Gal-3 Expression and Myocardial Fibrosis |
| Modified Citrus Pectin | Myocardial Injury | 1 | PM | 31709320 | 📋 | Acute Kidney Injury Induces Remote Cardiac Damage and Dysfunction Through the Galectin-3 Pathway |
| Modified Citrus Pectin | Myocardial Injury | 3 | PM | 29674526 | 📋 | Galectin-3 down-regulates antioxidant peroxiredoxin-4 in human cardiac fibroblasts: a new pathway to induce cardiac damage |
| Modified Citrus Pectin | Myocardial Injury | 2 | PM | 29361517 | 📋 | Inhibition of galectin-3 ameliorates the consequences of cardiac lipotoxicity in a rat model of diet-induced obesity |
| Modified Citrus Pectin | Myocardial Ischemia-Reperfusion | 1 | PM | 31270370 | 📋 | Myocardial Injury After Ischemia/Reperfusion Is Attenuated By Pharmacological Galectin-3 Inhibition |
| Modified Citrus Pectin | Myocarditis | 1 | PM | 26238446 | 📋 | Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension |
| Modified Citrus Pectin | Subarachnoid Hemorrhage | 1 | PM | 30355205 | 📋 | Modified Citrus Pectin Prevents Blood-Brain Barrier Disruption in Mouse Subarachnoid Hemorrhage by Inhibiting Galectin-3 |
